|
|||||
|
|

Pet company Central Garden & Pet (NASDAQ:CENT) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 6% year on year to $617.4 million. Its non-GAAP profit of $0.21 per share was 51.8% above analysts’ consensus estimates.
Is now the time to buy CENT? Find out in our full research report (it’s free for active Edge members).
Central Garden & Pet’s Q4 results were met with a negative market reaction as sales declined year on year, which management attributed primarily to the timing of retailer inventory shipments and ongoing portfolio optimization. CEO Nicholas Lahanas noted that efforts to simplify operations and focus on higher-margin categories continued to support profitability, while CFO Bradley Smith pointed to improved gross margins and disciplined cost control. Temporary shipment holds and the transition to a more streamlined product mix also weighed on the top line, but management emphasized that categories such as rawhide, wild bird, and animal health performed well, helping offset broader sales declines.
Looking ahead, Central Garden & Pet’s full-year outlook is anchored by continued investment in innovation, digital capabilities, and selective M&A, as management signals a shift from foundational cost measures to a more growth-oriented strategy. Lahanas stated, “We really recognize that it’s time to pivot and focus on a growth mindset,” highlighting a plan to drive organic growth through product development, private label expansion, and increased digital engagement. CFO Smith cautioned that tariffs and ongoing portfolio changes will remain headwinds, but the company believes targeted pricing actions and further supply chain improvements can help mitigate these challenges.
Management identified shifting shipment timing, portfolio adjustments, and cost discipline as the main drivers of the quarter’s results, while also emphasizing progress in innovation and selective tuck-in acquisitions.
Central Garden & Pet expects growth initiatives, portfolio optimization, and margin management to shape performance over the next year, with innovation and tariff mitigation as key themes.
In coming quarters, StockStory’s team will be watching (1) the pace at which innovation and digital initiatives translate into new product adoption and sales, (2) how effectively Central Garden & Pet mitigates continued tariff and supply chain headwinds, and (3) the resumption of top-line growth as portfolio optimization winds down. Execution in M&A and the ability to sustain margin gains will also be key indicators of future performance.
Central Garden & Pet currently trades at $34.26, down from $35.11 just before the earnings. At this price, is it a buy or sell? See for yourself in our full research report (it’s free).
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
| Mar-06 | |
| Mar-04 | |
| Mar-03 | |
| Mar-03 | |
| Mar-03 | |
| Mar-02 | |
| Mar-02 | |
| Mar-02 | |
| Mar-02 | |
| Feb-27 | |
| Feb-26 | |
| Feb-24 | |
| Feb-23 | |
| Feb-19 | |
| Feb-18 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about Finviz Elite